跳至主要内容
临床试验/NCT00201903
NCT00201903已完成不适用

The Roles of Tissue Factor in Malignant Gliomas

Ontario Clinical Oncology Group (OCOG)6 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
6

研究概览

简要总结

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

详细描述

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • participation in PRODIGE
  • adult patients
  • newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas
  • undergone craniotomy or stereotactic biopsy > 2 days and < 4 weeks before

排除标准

  • have known hereditary thrombophilia
  • are receiving experimental antiangiogenic therapy

研究者

发起方
Ontario Clinical Oncology Group (OCOG)
申办方类型
Other

研究点 (6)

Loading locations...

相似试验

The Roles of Tissue Factor in Malignant Gliomas | 临床试验